春立醫療(01858.HK):林一鳴辭任非執行董事
格隆匯3月11日丨春立醫療(01858.HK)公告,公司董事會獲公司非執行董事林一鳴告知,彼被裁定於中華人民共和國觸犯非國家工作人員受賄罪。
根據中國北京市昌平區人民法院於2019年9月作出的判決,林被發現於中國以非國家工作人員身份收受賄賂,違反中國刑法第163(1)條。此外,判決指出林承認控罪,罪名成立,被判有期徒刑九個月。
鑑於以上所述,林一鳴辭任公司非執行董事及公司審核委員會成員職務,均於2020年3月11日生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.